发明名称 |
Sustained release beadlets containing stavudine stabilised by magnesium stearate |
摘要 |
Extended dosage forms of stavudine are provided comprising beadlets formed by extrusion-spheronisation and coated with a seal coating. The beadlets are also coated with a modified release coating such that a hard gelatin capsule containing such beadlets will provide blood levels of stavudine over approximately 24 hours. The beadlets are prepared from a dry blend of stavudine, a spheronising agent, a suitable diluent and a stabilizing amount of magnesium stearate. The magnesium stearate, in contrast to other similar pharmaceutical adjuncts, has been found to stabilize stavudine against degradation due to hydrolysis in the presence of the limited amount of water necessary for the extrusion-spheronisation process. Also provided are hard gelatin capsules containing, in addition to the stavudine beadlets, similar beadlets containing other therapeutic agents utilised to treat retroviral infections.
|
申请公布号 |
NZ522250(A) |
申请公布日期 |
2004.09.24 |
申请号 |
NZ20010522250 |
申请日期 |
2001.03.29 |
申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
ABRAMOWITZ, ROBERT;O'DONOGHUE, DENISE;JAIN, NEMICHAND B |
分类号 |
A61J3/07;A61K9/16;A61K9/48;A61K9/50;A61K9/52;A61K31/4402;A61K31/4965;A61K31/513;A61K31/522;A61K31/7072;A61K31/7076;A61K45/00;A61K47/04;A61K47/10;A61K47/12;A61K47/14;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61P31/12;A61P31/18;(IPC1-7):A61K31/707;A61K31/707 |
主分类号 |
A61J3/07 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|